WallStreetZenWallStreetZen

NASDAQ: ASND
Ascendis Pharma A Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Ascendis Pharma A earnings were -$393.8M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ASND earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$40.1M, down 63.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ASND reported annual earnings of -$393.8M, with -26.4% growth.

ASND earnings history

Current Revenue
$378.8M
Current Earnings
-$393.8M
Current Profit Margin
-104%

ASND Return on Equity

Current Company
N/A
Current Industry
-2%
Current Market
34.1%

ASND undefined

Current Company
-39.4%
Current Industry
-0.4%
ASND is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ASND announces earnings.

ASND undefined

Current Company
-100.58%
Current Industry
5.9%
ASND's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ASND vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ASND-$266.15M-$393.84MN/A-$6.80
EXEL$737.90M$521.27M+11.17%$1.80
MRNA-$3.42B-$3.56BN/A-$9.28
INCY$406.83M$21.27M-39.68%$0.29
BMRN$650.86M$426.86M-16.91%$2.25
View Top Biotech Stocks

Ascendis Pharma A Earnings Reports & History FAQ

What were Ascendis Pharma A's earnings last quarter?

Ascendis Pharma A (NASDAQ: ASND) reported Q4 2024 earnings per share (EPS) of -$0.67, up 61.02% year over year. Total ASND earnings for the quarter were -$40.07 million. In the same quarter last year, Ascendis Pharma A's earnings per share (EPS) was -$1.71.

If you're new to stock investing, here's how to buy Ascendis Pharma A stock.

Is Ascendis Pharma A profitable or losing money?

As of the last Ascendis Pharma A earnings report, Ascendis Pharma A is currently losing money. Ascendis Pharma A's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$393.84 million, a 26.38% decrease year over year.

What was ASND's earnings growth in the past year?

As of Ascendis Pharma A's earnings date in Q2 2025, Ascendis Pharma A's earnings has grown year over year. ASND earnings in the past year totalled -$393.84 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.